Brett Matthew Hall - 22 Dec 2021 Form 4 Insider Report for Immuneering Corp (IMRX)

Role: CHIEF SCIENTIFIC OFFICER
Signature: /s/ Michael D. Bookman, as Attorney-In-Fact for Brett M. Hall
Issuer symbol: IMRX
Transactions as of: 22 Dec 2021
Transactions value $: $0
Form type: 4
Filing time: 22 Dec 2021, 16:30:05 UTC
Previous filing: 04 Aug 2021
Next filing: 14 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMRX	Class A Common Stock	Award		+323K	+5047.57%		329K	22 Dec 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Calculated using a value based on the average of the daily volume weighted average prices of the Class A common stock on the Nasdaq Stock Exchange for the 30-trading day period ending on and including the trading day immediately prior to the Closing Date, as that term is defined in the Share Purchase Agreement, dated as of December 22, 2021, by and among Immuneering Corporation, BioArkive, Inc. ("BioArkive"), and each of the shareholders of BioArkive, including Dr. Hall.

Content

Calculated using a value based on the average of the daily volume weighted average prices of the Class A common stock on the Nasdaq Stock Exchange for the 30-trading day period ending on and including the trading day immediately prior to the Closing Date, as that term is defined in the Share Purchase Agreement, dated as of December 22, 2021, by and among Immuneering Corporation, BioArkive, Inc. ("BioArkive"), and each of the shareholders of BioArkive, including Dr. Hall.